Major – Recall of losartan
April 26, 2019 - Major announced a voluntary recall of losartan tablets due to the detection of trace amounts of an unexpected impurity, N-Methylnitrosobutyric acid (NMBA) found in the active pharmaceutical ingredient manufactured by Hetero Labs Limited.
Download PDF
